DK0436717T3 - System til anvendelse ved en fremgangsmåde til terapeutisk eller diagnostisk behandling - Google Patents

System til anvendelse ved en fremgangsmåde til terapeutisk eller diagnostisk behandling

Info

Publication number
DK0436717T3
DK0436717T3 DK90914303T DK90914303T DK0436717T3 DK 0436717 T3 DK0436717 T3 DK 0436717T3 DK 90914303 T DK90914303 T DK 90914303T DK 90914303 T DK90914303 T DK 90914303T DK 0436717 T3 DK0436717 T3 DK 0436717T3
Authority
DK
Denmark
Prior art keywords
medical agent
therapeutic
diagnostic treatment
normal clearance
obviate
Prior art date
Application number
DK90914303T
Other languages
English (en)
Inventor
Stephen W Maddock
Original Assignee
Mitra Medical Technology Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitra Medical Technology Ab filed Critical Mitra Medical Technology Ab
Priority claimed from PCT/US1990/004341 external-priority patent/WO1991001749A1/en
Application granted granted Critical
Publication of DK0436717T3 publication Critical patent/DK0436717T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
DK90914303T 1989-08-02 1990-08-02 System til anvendelse ved en fremgangsmåde til terapeutisk eller diagnostisk behandling DK0436717T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38866489A 1989-08-02 1989-08-02
PCT/US1990/004341 WO1991001749A1 (en) 1989-08-02 1990-08-02 Method of treatment with medical agents

Publications (1)

Publication Number Publication Date
DK0436717T3 true DK0436717T3 (da) 2003-05-05

Family

ID=23535010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90914303T DK0436717T3 (da) 1989-08-02 1990-08-02 System til anvendelse ved en fremgangsmåde til terapeutisk eller diagnostisk behandling

Country Status (6)

Country Link
US (2) US5474772A (da)
EP (1) EP1327454A3 (da)
AT (1) ATE233100T1 (da)
DE (1) DE69034042T2 (da)
DK (1) DK0436717T3 (da)
ES (1) ES2188580T3 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5753227A (en) * 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
US7166295B1 (en) 1995-05-26 2007-01-23 Meir Strahilevitz Methods of treatment and diagnostic visualization, particularly in cancer
US8951499B2 (en) * 1996-02-08 2015-02-10 University Of Washington Trifunctional reagent for conjugation to a biomolecule
US20010023288A1 (en) * 1999-07-07 2001-09-20 Wilbur D. Scott Trifunctional reagent for conjugation to a biomolecule
ATE365562T1 (de) * 1996-05-03 2007-07-15 Immunomedics Inc Zielgerichtete kombinations-immuntherapie für krebs
US7011812B1 (en) 1996-05-03 2006-03-14 Immunomedics, Inc. Targeted combination immunotherapy of cancer and infectious diseases
US5817770A (en) 1997-03-21 1998-10-06 Drug Abuse Sciences, Inc. Cocaethylene immunogens and antibodies
US20050271673A1 (en) * 1998-07-07 2005-12-08 Wilbur D S Trifunctional reagent for conjugation to a biomolecule
ATE368477T1 (de) * 2000-06-20 2007-08-15 Immunomedics Inc Zielgerichtete kombinationsimmuntherapie für krebs und infektionskrankheiten
WO2002030474A1 (en) * 2000-10-12 2002-04-18 Mitra Medical Technology Ab Kit for intraperitoneal administration and extracorpeal removal of a drug
AU2003290506A1 (en) * 2002-04-02 2004-04-30 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
AU2003234194A1 (en) * 2002-04-23 2003-11-10 Meir Strahilevitz Methods and devices for targeting a site in a mammal and for removing species from a mammal
WO2006017763A2 (en) * 2004-08-04 2006-02-16 Aspira Biosystems, Inc. Capture and removal of biomolecules from body fluids using partial molecular imprints
JP2008520287A (ja) 2004-11-16 2008-06-19 メドラッド インコーポレーテッド 薬剤注入に対する患者搬送関数を決定し、患者反応をモデル化するシステム及び方法
HUE034171T2 (en) 2004-11-24 2018-02-28 Bayer Healthcare Llc Tools, systems and procedures for fluid transfer
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2008085421A2 (en) 2006-12-29 2008-07-17 Medrad, Inc. Patient-based parameter generation systems for medical injection procedures
JP5437240B2 (ja) 2007-07-17 2014-03-12 メドラッド インコーポレーテッド 心肺機能の評価、及び流体搬送の手順のパラメータを決定する装置、システム及び方法
US8165663B2 (en) * 2007-10-03 2012-04-24 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation
US8285366B2 (en) 2007-10-04 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a local bypass
US8285367B2 (en) * 2007-10-05 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a reservoir
US9421330B2 (en) 2008-11-03 2016-08-23 Bayer Healthcare Llc Mitigation of contrast-induced nephropathy
US8758330B2 (en) 2010-03-05 2014-06-24 The Invention Science Fund I, Llc Device for actively removing a target cell from blood or lymph of a vertebrate subject
US8246565B2 (en) * 2009-02-25 2012-08-21 The Invention Science Fund I, Llc Device for passively removing a target component from blood or lymph of a vertebrate subject
US8430831B2 (en) * 2009-02-25 2013-04-30 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
US8317737B2 (en) 2009-02-25 2012-11-27 The Invention Science Fund I, Llc Device for actively removing a target component from blood or lymph of a vertebrate subject
US20110295175A1 (en) * 2010-03-16 2011-12-01 Marv Enterprises Llc Sequential Extracoporeal Treatment of Bodily Fluids
JP6025718B2 (ja) 2010-06-24 2016-11-16 ベイヤー メディカル ケア インク． 注入プロトコルのための医薬品の伝播およびパラメータ生成のモデル
EP2850418B1 (en) 2012-05-14 2019-02-20 Bayer Healthcare LLC Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage
US9555379B2 (en) 2013-03-13 2017-01-31 Bayer Healthcare Llc Fluid path set with turbulent mixing chamber, backflow compensator
US10898638B2 (en) 2016-03-03 2021-01-26 Bayer Healthcare Llc System and method for improved fluid delivery in multi-fluid injector systems
EP3538546B1 (en) 2016-11-14 2025-01-08 Novartis AG Compositions, methods, and therapeutic uses related to fusogenic protein minion
US12263326B2 (en) 2016-11-14 2025-04-01 Bayer Healthcare Llc Methods and systems for verifying the contents of a syringe used for medical fluid delivery
US11786652B2 (en) 2017-08-31 2023-10-17 Bayer Healthcare Llc System and method for drive member position and fluid injector system mechanical calibration
CA3068739A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc Fluid path impedance assessment for improving fluid delivery performance
US11478581B2 (en) 2017-08-31 2022-10-25 Bayer Healthcare Llc Fluid injector system volume compensation system and method
EP3675931B1 (en) 2017-08-31 2021-08-11 Bayer Healthcare LLC Injector pressure calibration system and method
EP3675929B1 (en) 2017-08-31 2026-05-13 Bayer Healthcare LLC Method for dynamic pressure control in a fluid injector system
GB201717555D0 (en) * 2017-10-25 2017-12-06 Nonwovens Innovation & Res Institute Ltd Blood filter
CN116966369A (zh) 2018-04-19 2023-10-31 拜耳医药保健有限公司 流体注入器中空气检测的系统和方法
CN112823031B (zh) 2018-08-28 2023-08-15 拜耳医药保健有限责任公司 防止流体回流的流体注入器系统、方法和计算机程序产品
CA3111209A1 (en) 2018-08-28 2020-03-05 Bayer Healthcare Llc Fluid injector system with improved ratio performance
WO2022115390A1 (en) * 2020-11-25 2022-06-02 Cytostorm, Inc. Extracorporeal plasma separation, adsorption, and delivery systems and methods

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate
US4223672A (en) * 1979-02-08 1980-09-23 Baxter Travenol Laboratories, Inc. Variable volume plasma treatment chamber for an apparatus for the extracorporeal treatment of disease
US4215688A (en) * 1979-02-09 1980-08-05 Baxter Travenol Laboratories, Inc. Apparatus for the extracorporeal treatment of disease
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
US4687808A (en) * 1982-08-12 1987-08-18 Biospecific Technologies, Inc. Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors
CA1221307A (en) * 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent and process for preparing the same
CA1236738A (en) * 1983-06-01 1988-05-17 Mark R. Honard Therapeutic device
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4863713A (en) * 1986-06-23 1989-09-05 The Board Of Trustees Of Leland Stanford Jr. Univ. Method and system for administering therapeutic and diagnostic agents
US4877599A (en) * 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US4800016A (en) * 1986-11-24 1989-01-24 The University Of Michigan Extracorporeal blood de-heparinization system
DE3705637A1 (de) * 1987-02-21 1988-09-29 Bissendorf Peptide Gmbh Vorrichtung zur entfernung von lokal applizierten wirkstoffen gegen solide tumoren
US4846786A (en) * 1987-04-30 1989-07-11 Massachusetts Institute Of Technology Bioreactor containing suspended, immobilized species
US4885207A (en) * 1987-07-13 1989-12-05 Uop Biocompatible protein or ligand immobilization system
US4865841A (en) * 1987-10-23 1989-09-12 Imre Corporation Methods and compositions for transient elimination of humoral immune antibodies
US5069662A (en) * 1988-10-21 1991-12-03 Delcath Systems, Inc. Cancer treatment
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
AU648015B2 (en) * 1989-01-23 1994-04-14 Akzo N.V. Site specific in-vivo activation of therapeutic drugs
US5252466A (en) * 1989-05-19 1993-10-12 Biotechnology Research And Development Corporation Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them
WO1991001749A1 (en) * 1989-08-02 1991-02-21 Cobe Laboratories, Inc. Method of treatment with medical agents
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal

Also Published As

Publication number Publication date
EP1327454A2 (en) 2003-07-16
ES2188580T3 (es) 2003-07-01
US6046225A (en) 2000-04-04
DE69034042D1 (de) 2003-04-03
ATE233100T1 (de) 2003-03-15
DE69034042T2 (de) 2003-07-17
US5474772A (en) 1995-12-12
EP1327454A3 (en) 2003-12-03

Similar Documents

Publication Publication Date Title
ES2188580T3 (es) Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico.
SE9100142D0 (sv) A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose
BR8203384A (pt) Sistema para tratamento do sangue de um paciente
ES2022856B3 (es) Dispositivo para el tratamiento de la sangre en circulaciones extracorporales
ATE127352T1 (de) Hämofiltrationssystem.
SE8505438L (sv) System for uppsamling, behandling och aterforing av en patients blod
DE68907402D1 (de) Durchflussregler fuer medizinloesungen oder fuer bluttransfusionsgeraete.
SE8502758L (sv) System for styrning av en medicinsk behandling, t ex dialys
ATE81018T1 (de) Therapeutische oder radiodiagnostische substanz.
SE8506029L (sv) Hjert-lungsystem avsett for syresettning av en patients blod
DE3767196D1 (de) Ventileinrichtung fuer ein system zur behandlung eines patienten durch photoaktivierung.
DK199786A (da) Radiofarmaceutisk forbindelse til diagnostisk anvendelse, fremgangsmaade og udstyr til anvendelse deraf
Stone et al. Mobilization of Radioactive Sodium from the Gastrocnemius Muscle of the Dog.
SE403438B (sv) Anordning for behandling av blod eller liknande omtaliga vetskor
CA2037933A1 (en) Method of Treatment with Medical Agents
GB2108400A (en) Method and apparatus for treating blood and the like
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
GB8825171D0 (en) Agent for improving reduced functions of organs caused by inhibited blood circulation
IT8148480A0 (it) Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero
RU93057899A (ru) Способ лечения гнойного холангита и холангиогенных абсцессов печени
ES556906A0 (es) Sistema de control de la temperatura de la sangre de un paciente en cirujia cardiaca
SE7903631L (sv) Forfarande for bestemning av kalciumnivan i blod
RU93001215A (ru) Способ определения показаний к лечению гемоспленоперфузией при гнойном перитоните
ITMI941157A0 (it) Apparato magnetoterapico per la riattivazione della circolazione sanguigna per il lenimento di mialgie, dolori articolari per la cura di traumi muscolari o simili
RU93027720A (ru) Способ лечения и профилактики острой лучевой болезни